Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
120 hedge funds and large institutions have $267M invested in Arena Pharmaceuticals Inc in 2015 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 36 reducing their positions, and 21 closing their positions.
61% more call options, than puts
Call options by funds: $3.16M | Put options by funds: $1.97M
17% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 36
8% less funds holding
Funds holding: 130 → 120 (-10)
38% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 21
59% less capital invested
Capital invested by funds: $648M → $267M (-$382M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$9.11M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$7.64M |
| 3 |
SAM
Senzar Asset Management
New York
|
+$6M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.17M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
-$32.5M |
| 2 |
DM
Deerfield Management
New York
|
-$7.96M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$2.39M |
| 4 |
CCMH
Cornerstone Capital Management Holdings
New York
|
-$1.28M |
| 5 |
CC
Callan Capital
La Jolla,
California
|
-$1.08M |
ARNA Hedge Fund Activity: Q3 2015 in Review
120 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q3 2015, worth a combined $267M — down 59% from $648M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of ARNA and 13 opened new positions — a net loss of 8 holders — while 36 trimmed existing stakes and 42 added.
The largest buyer was State Street, adding an estimated $9.11M. The largest seller was OppenheimerFunds, exiting entirely with an estimated $32.5M sold.
- 120 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q3 2015, down from 130 in Q2 2015.
- Funds reported $267M of Arena Pharmaceuticals Inc stock for Q3 2015, down 59% quarter-over-quarter.
- 13 funds opened new Arena Pharmaceuticals Inc positions in Q3 2015 and 21 closed out, a net change of -8 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q3 2015 was State Street, an estimated $9.11M added.
- The largest Arena Pharmaceuticals Inc seller in Q3 2015 was OppenheimerFunds, an estimated $32.5M sold.
Based on aggregated 13F filings for Q3 2015.